Jiong Li, Xiangjun Ma, Faying Xu, Yuanliang Yan, & Weiqing Chen. (2024). Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1. Taylor & Francis Group.
Chicago Style (17th ed.) CitationJiong Li, Xiangjun Ma, Faying Xu, Yuanliang Yan, and Weiqing Chen. Babaodan Overcomes Cisplatin Resistance in Cholangiocarcinoma via Inhibiting YAP1. Taylor & Francis Group, 2024.
MLA (9th ed.) CitationJiong Li, et al. Babaodan Overcomes Cisplatin Resistance in Cholangiocarcinoma via Inhibiting YAP1. Taylor & Francis Group, 2024.
Warning: These citations may not always be 100% accurate.